Covestor’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17K Buy
115
+44
+62% +$4.79K 0.01% 1244
2026
Q1
$7K Sell
71
-258
-78% -$25.9K ﹤0.01% 1652
2025
Q4
$34K Hold
329
0.02% 1050
2025
Q3
$21K Hold
329
0.01% 1253
2025
Q2
$17K Sell
329
-1
-0.3% -$45 0.01% 1308
2025
Q1
$14K Buy
330
+1
+0.3% +$43 0.01% 1307
2024
Q4
$10K Buy
329
+1
+0.3% +$28 0.01% 1533
2024
Q3
$8K Sell
328
-257
-44% -$7.27K 0.01% 1654
2024
Q2
$17K Buy
585
+301
+106% +$7.01K 0.01% 1253
2024
Q1
$6K Buy
284
+20
+8% +$429 ﹤0.01% 1767
2023
Q4
$7K Sell
264
-1
-0.4% -$26 ﹤0.01% 1718
2023
Q3
$8K Sell
265
-4
-1% -$141 0.01% 1543
2023
Q2
$10K Hold
269
0.01% 1430
2023
Q1
$6K Buy
269
+101
+60% +$2.88K 0.01% 1514
2022
Q4
$5K Hold
168
﹤0.01% 1566
2022
Q3
$9K Buy
168
+63
+60% +$3.23K 0.01% 1301
2022
Q2
$4K Sell
105
-2
-2% -$99 ﹤0.01% 1461
2022
Q1
$7K Buy
107
+46
+75% +$3.15K ﹤0.01% 1404
2021
Q4
$6K Buy
+61
New +$6.31K 0.01% 1224

Other funds holding GH

Covestor's GH Position: Q2 2026 in Review

Covestor increased its Guardant Health (GH) stake by 62% in Q2 2026, buying an estimated $4.79K and bringing the position to 115 shares worth $17K. The position accounts for 0.01% of the portfolio, ranked #1244.

Covestor first reported a position in GH in Q4 2021 and has held it in 19 quarters since. The position peaked at $34K in Q4 2025. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Covestor held 115 shares of Guardant Health worth $17K as of Q2 2026.
  • Covestor bought 44 Guardant Health shares in Q2 2026, an estimated $4.79K.
  • Guardant Health made up 0.01% of Covestor's portfolio in Q2 2026, its #1244 holding.
  • Covestor first reported a position in Guardant Health in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Guardant Health position peaked at $34K in Q4 2025.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.